These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 30634887

  • 1. Circulating neuregulin-1 levels in polycystic ovary syndrome.
    Arpacı H.
    J Obstet Gynaecol; 2019 May; 39(4):504-509. PubMed ID: 30634887
    [Abstract] [Full Text] [Related]

  • 2. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M, Sahin Ersoy G, Yayla Abide C, Sanverdi İ, Devranoglu B, Kutlu T, Çevik Ö.
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [Abstract] [Full Text] [Related]

  • 3. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 4. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [Abstract] [Full Text] [Related]

  • 5. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study.
    Temur M, Calan M, Akşit M, Yılmaz Ö, Çift T, Akselim B, Dinçgez Çakmak B, Üstünyurt E.
    Ginekol Pol; 2017 Oct; 88(10):517-522. PubMed ID: 29192411
    [Abstract] [Full Text] [Related]

  • 6. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M, Duran C, Guney I, Elmas H, Ayhan M, Erdem SS.
    Clin Investig Arterioscler; 2020 Oct; 32(6):256-262. PubMed ID: 32773256
    [Abstract] [Full Text] [Related]

  • 7. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N, Hashim M, Sayed M, Said M.
    Dis Markers; 2009 Mar; 26(4):163-70. PubMed ID: 19729797
    [Abstract] [Full Text] [Related]

  • 9. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H, Meng J, Xing H, Nie S, Xu M, Zhang S, Jin Y, Sun T, Huang H, Zhang H, Wang D, Liu L.
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [Abstract] [Full Text] [Related]

  • 10. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [Abstract] [Full Text] [Related]

  • 11. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 12. METFORMIN EFFECTS ON NEUREGULIN-1 IN POLYCYSTIC OVARIAN WOMEN.
    Tawfeq M, Sarhat E.
    Georgian Med News; 2023 Apr; (337):56-62. PubMed ID: 37354674
    [Abstract] [Full Text] [Related]

  • 13. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
    Karadağ C, Yoldemir T.
    J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
    [Abstract] [Full Text] [Related]

  • 14. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC, Soares NP, Costa EC, de Sá JC, Azevedo GD, Lemos TM.
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [Abstract] [Full Text] [Related]

  • 15. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O.
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [Abstract] [Full Text] [Related]

  • 16. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R, Kichler J, Calhoun M.
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [Abstract] [Full Text] [Related]

  • 17. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
    Calan M, Yilmaz O, Kume T, Unal Kocabas G, Yesil Senses P, Senses YM, Temur M, Gursoy Calan O.
    Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
    [Abstract] [Full Text] [Related]

  • 18. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
    Tarkun I, Arslan BC, Cantürk Z, Türemen E, Sahin T, Duman C.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
    [Abstract] [Full Text] [Related]

  • 19. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U, Duran C, Ecirli S.
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [Abstract] [Full Text] [Related]

  • 20. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F, Dorizzi R, Castello R, Maffeis C, Spiazzi G, Zoppini G, Muggeo M, Moghetti P.
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.